Close
Almac
Achema middle east

Articles

Delivery logistics is critical to COVID-19 vaccine availability

The opening months of 2021 have revealed the logistical and political intricacies of COVID-19 vaccine manufacturing and deployment. The unprecedented requirement of vaccinating the world against a single virus has demonstrated the power of modern medicine and logistics capabilities. The...

COVID-19 Impact on Pharmaceutical Industry

Despite the effects of the COVID-19 pandemic, 2020 witnessed accelerated growth taking place in the pharmaceutical contract services market which has persisted into 2021. Investment continues throughout the pharmaceutical industry, driving a need for innovation across contract development services,...

Air Cargo Trends in a Pandemic World

Previous predictions in pharmaceutical transportation trends, highlighting declining air passenger numbers and air freight demand increasing, have been pandemic propelled. Coronavirus continues causing worldwide disruption and it is anticipated its industry impact will continue throughout 2021 and beyond. Pandemic Response...

Solid-form development: the key to API success?

The success and effectiveness of an active pharmaceutical ingredient (API) solid depends on more than just its chemical make-up; the physical properties of the particles that compose the solid, play an equally important role. From the shape of the individual...

COVID-19 Impact on Pharmaceutical Industry Comment

Reflecting on the beginning of the COVID-19 outbreak 12 months ago, it is clear that those pharma companies who responded early to the warning signs – like ChargePoint Technology – were most effective at maintaining business continuity over the...

Time for a Truly Agile, Global Pharmaceutical Supply chain

Agile supply chains have distinct attributes that help manage vulnerability, disruptions and risk. Recent events demonstrate how valuable an agile process team approach can be to meet new global supply chain realities. As the COVID-19 pandemic unfolded, there were warning...

Fill and Finish in Clinical Development: Getting it Right from the Start

Regardless of size, pharma and biotech companies alike encounter numerous challenges in the process of fill and finish of drugs for clinical development, including any subsequent scale-up steps. These challenges encompass the increased complexity of regulatory requirements, processes and...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »